Analysis of cGMP Warning Letters Issued by the FDA in Q1 2023
Program: Applied Biotechnology Master's — Business Management
Location: Not Specified (remote)
Student: Natalia Schoch
The objective of this project was to perform a thorough analysis of FDA warning letters sent in early 2023, regarding cGMP matters, looking for industry-wide trends, and to provide manufacturer recommendations.